Pathophysiology, Diagnosis, and Management of Takayasu Arteritis: A Review of Current Advances
Sagar Bhandari,Samia Rauf R Butt,Anzal Ishfaq,Mohamed H Attaallah,Chukwuyem Ekhator,Raghu Halappa Nagaraj,Asmita Mulmi,Muhammad Kamran,Amanda Karski,Karla I Vargas,Slobodan Lazarevic,Mohammad Uzair Zaman,Gautham Lakshmipriya Vetrivendan,S M Iram Shahzed,Archana Das,Vikas Yadav,Sophia B Bellegarde,Ashraf Ullah
DOI: https://doi.org/10.7759/cureus.42667
2023-07-29
Cureus
Abstract:Takayasu arteritis (TA) is a rare, chronic, inflammatory vasculitis that primarily affects large arteries, causing significant morbidity and mortality. This review provides an overview of the pathophysiology, diagnosis, and management of TA based on current advances in the field. TA is characterized by autoimmune-mediated inflammation, vascular remodeling, and endothelial dysfunction. The disease progresses through three stages (active, chronic, and healing phase) each presenting distinct clinical features. Diagnosis of TA can be challenging due to non-specific clinical manifestations and the lack of specific diagnostic tests. Various imaging modalities, such as angiography, ultrasound, and Doppler techniques, play a crucial role in the diagnosis of TA by visualizing arterial involvement and assessing disease extent. Management of TA involves a multidisciplinary approach, with disease-modifying anti-rheumatic drugs (DMARDs) as the cornerstone of medical therapy. Synthetic and biologic DMARDs are used to induce remission, control inflammation, and prevent complications. Non-pharmacologic interventions, such as resistance exercises and curcumin supplementation, show potential benefits. Invasive interventions, including endovascular therapy and open surgery, are used for managing vascular lesions. However, challenges remain in disease understanding and management, including the heterogeneity of disease presentation and the lack of standardized treatment guidelines. The future of TA management lies in precision medicine, utilizing biomarkers and molecular profiling to personalize treatment approaches and improve patient outcomes. Further research is needed to unravel the underlying mechanisms of TA and develop targeted therapies.